Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

View source ↗

Summary

A clinical trial evaluating plasma HPV DNA and RNA as biomarkers to monitor cervical cancer response to surgery, radiation, and chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Florida | Conditions: Cervical Cancer, Human Papilloma Virus (HPV) | Status: RECRUITING